Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 62.58 |
| Open | 62.81 |
| Bid | 0.00 x 40000 |
| Ask | 0.00 x 1800 |
| Day's Range | 61.85 - 63.13 |
| 52 Week Range | 57.17 - 74.12 |
| Volume | |
| Avg. Volume | 8,285,567 |
| Market Cap | 79.122B |
| Beta (5Y Monthly) | 0.38 |
| PE Ratio (TTM) | 17.62 |
| EPS (TTM) | 3.58 |
| Earnings Date | Jul 27, 2022 - Aug 01, 2022 |
| Forward Dividend & Yield | 2.92 (4.63%) |
| Ex-Dividend Date | Jun 14, 2022 |
| 1y Target Est | 69.21 |
- Motley Fool
3 Top Dividend Stocks for Generating Passive Income
One great way to make passive income is to invest in dividend stocks. Here's why they selected AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Merck (NYSE: MRK). Keith Speights (AbbVie): Only the most elite dividend stocks become Dividend Kings.
- Zacks
Gilead (GILD) Announces Positive Data on Hepcludex for HDV
Gilead (GILD) Hepcludex meets the primary endpoint in a phase III study for the treatment of chronic hepatitis delta virus (HDV) infection at 48 weeks.
- News Direct
Gilead's Social Justice Experience Helps Raise Awareness of the Black Journey in the United States
Gilead is as passionately committed to championing inclusion and diversity, health equity and social justice issues, as it is to helping improve the lives of people with life-threatening diseases. ...
© 2022 Yahoo. All rights reserved.
